A case of febrile infection-related epilepsy syndrome requiring prolonged intensive care management: a trial of intravenous ketamine and intrathecal dexamethasone therapy-Reference-Cited by-同舟云学术

A case of febrile infection-related epilepsy syndrome requiring prolonged intensive care management: a trial of intravenous ketamine and intrathecal dexamethasone therapy

Published:2022 Issue:2 Volume:62 Page:123-129
ISSN:0009-918X
Container-title:Rinsho Shinkeigaku
language:en
Short-container-title:Rinsho Shinkeigaku

Author:

Ioku Tetsuya¹,Inoue Takeshi²,Kuki Ichiro²,Imai Keisuke¹,Yamamoto Atsushi¹,Cho Masanori¹

Affiliation:

1. Department of Neurology and Stroke Treatment, Kyoto First Red Cross Hospital

2. Child and Adolescent Epilepsy Center, Department of Pediatric Neurology, Osaka City General Hospital

Publisher

Societas Neurologica Japonica

Subject

Neurology (clinical)

Link

https://www.jstage.jst.go.jp/article/clinicalneurol/62/2/62_cn-001624/_pdf

Reference30 articles.

1. 1) Sakuma H, Awaya Y, Shiomi M, et al. Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol Scand 2010;121:251-256.

2. 2) Gaspard N, Hirsch LJ, Sculier C, et al. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives. Epilepsia 2018;59:745-752.

3. 3) 飯塚高浩．自己免疫性脳炎およびその類縁疾患における最近の進歩．臨床神経 2019;59:491-501.

4. 4) Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 2018;59:739-744.

5. 5) Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia 2011;52 Suppl 8:53-56.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical research progress on intrathecal glucocorticoids in the treatment of infections: A review;Medicine;2024-05-17

2. Multiple drugs;Reactions Weekly;2023-01-07